🇺🇸 Bisoprolol 2.5 mg in United States

82 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bradycardia — 15 reports (18.29%)
  2. Dizziness — 9 reports (10.98%)
  3. Drug Interaction — 9 reports (10.98%)
  4. Dyspnoea — 9 reports (10.98%)
  5. Hypotension — 8 reports (9.76%)
  6. Asthenia — 7 reports (8.54%)
  7. Chest Pain — 7 reports (8.54%)
  8. Fatigue — 7 reports (8.54%)
  9. Blood Pressure Increased — 6 reports (7.32%)
  10. Acute Kidney Injury — 5 reports (6.1%)

Source database →

Bisoprolol 2.5 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bisoprolol 2.5 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bisoprolol 2.5 mg in United States?

Imperial College London is the originator. The local marketing authorisation holder may differ — check the official source linked above.